You miss my point, mate. I think (well, I hope) that the FDA is...

You miss my point, mate.

I think (well, I hope) that the FDA is on our side, too. I think they want to take stem cells out of the back room and out into the light by finding a company that is doing it right, and making them jump through all the hoops. If the FDA does it right (and fairly), they will be able to say with a straight face: "See world, we told you we would and we did - we approved an allogenenic stem cell treatment. Now do it just like MSB did it (or better) and we will approve you, too!"

But those are only my thoughts and hopes.

Not worth much when I still harbour a grudge after our ODAC.
And after that Alzheimer's drug debacle.
And after Jakafi's single-arm trial.
And Remdesivir.
And Hydroxychlorquine.
And, and, and, and...

My thoughts and hopes are NOT definitive proof that the FDA WILL ever approve MSB's products.

The shorters LOVE that uncertainty.
The punters (and the market) HATE it.

So up and down the SP goes...until we have CERTAINTY.